Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
Atsushi Yamada(Kyoto University), Ajay Goel(City of Hope), Manabu Muto(Kyoto City Hospital), Naoshi Nishida(Kindai University Hospital), Hiroshi Ida(Kyoto Prefectural Police), Hajime Honjo(Otsu Red Cross Hospital), Toshihiro Kusaka(Kyoto Katsura Hospital), Makato Yagi(Yamagata University), Takahiro Horimatsu(Kyoto University), Yoshiyuki Ueno(Yamagata Prefectural University of Health Sciences), Yu Sasaki(Yamagata University), Yusuke Amanuma(Chiba Cancer Center), Tadayuki Kou(Kitano Hospital), Norio Yukawa(Yokohama City University), C. Richard Boland(University of California San Diego), Osamu Kikuchi(Kyoto University), Atsushi Nakajima(Yokohama City University Hospital), Yoshinaga Okugawa(Mie University Hospital), Tsutomu Chiba(Kyoto University), Takuma Higurashi(Yokohama City University)
Cited by 157
Related Papers
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
|Gastroenterology|2015|814
Pathways of Colorectal Carcinogenesis
|Gastroenterology|2019|594
Molecular Classification and Correlates in Colorectal Cancer
|Journal of Molecular Diagnostics|2007|460
Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
|Annals of Surgical Oncology|2009|324